On December 8, the 2024 Asia-Pacific
Transplant Oncology Symposium and the Transplantation and Regenerative Medicine
Conference of West China Hospital (WCH), hosted by the International Liver
Transplantation Society (ILTS) and organized by WCH and the Sichuan
International Medical Exchange Promotion Association, was inaugurated at Huaxi
Campus. This marks the first time the Asia-Pacific Transplant Oncology
Symposium has been held in China, attracting 48 global organ transplantation
experts, oncologists, and hepatologists from 14 countries and regions,
including China, Singapore, Japan, the United States, the United Kingdom,
Canada, South Korea, India, Italy, Ireland, Spain, Norway, Egypt, and Hong
Kong.
The event brought together renowned experts
such as Professor Vincenzo Mazzaferro, the formulator of the global liver
transplantation standard (Milan criteria) from the University of Milan, Italy,
ILTS President Professor Tim Meyer, Professor Gonzalo Sapisochin from the
University of Toronto, Canada, Academician Dong Jiahong from the Chinese
Academy of Engineering, and President Zhou Jian from Zhongshan Hospital
affiliated with Fudan University. They convened to discuss the frontiers and
trends in transplant oncology, promoting technical exchange and cooperation. WCH’s
Party Secretary Cheng Yongzhong and Vice President Wu Hong attended the opening
ceremony and delivered speeches.
Party Secretary Cheng emphasized the
hospital's commitment to international cooperation and multidisciplinary
innovation, expressing hopes to strengthen collaboration with the International
Liver Transplantation Society through this conference, bringing new hope to
medical advancement and more benefits to patients.
Professor Vincenzo Mazzaferro highlighted
that China has the largest number of cases globally, and high-quality research
requires substantial case data support. He stressed that differences exist
between Eastern and Western populations, including the Chinese, in terms of
etiology and pathogenesis, and that consensus or guidelines must be based on
case data from multiple countries across the East and West to more
comprehensively address challenges in oncology and transplantation.
The conference featured a variety of
formats, including thematic sharing, discussions, and case sharing, also
reached consensus on frontier and hot topics in the field of transplant
oncology and planned international multicenter clinical research.
"Transplant oncology" is an
emerging concept that integrates transplantation, oncology, immunology,
hepatology, gastroenterology, and radiology, adopting a multidisciplinary
approach to optimize clinical treatment for patients with malignant tumors of
the liver and biliary tract, especially those considered unresectable. Over the
past decade, with the popularization of organ donation awareness and the
advancement of transplantation technology, the field of transplant oncology has
rapidly developed, benefiting a large number of cancer patients.